Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019
Health Services Research · 2023
DOI: 10.1111/1475-6773.14200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Research, 2023. Verfasst von Avik Chatterjee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center/Boston Univ…. Hauptthemen laut MEDLINE: Pharmacies, Drug Overdose, Pharmacy, Opioid-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, ACL HHS.
Abstract (Originalsprache)
Objective
Accurate naloxone distribution data are critical for planning and prevention purposes, yet sources of naloxone dispensing data vary by location, and completeness of local datasets is unknown. We sought to compare available datasets in Massachusetts, Rhode Island, and New York City (NYC) to a commercially available pharmacy national claims dataset (Symphony Health Solutions). Data Sources and Study Setting We utilized retail pharmacy naloxone dispensing data from NYC (2018–2019), Rhode Island (2013–2019), and Massachusetts (2014–2018), and pharmaceutical claims data from Symphony Health Solutions (2013–2019). Study Design We conducted a descriptive, retrospective, and secondary analysis comparing naloxone dispensing events (NDEs) captured via Symphony to NDEs captured by local datasets from the three jurisdictions between 2013 and 2019, when data were available from both sources, using descriptive statistics, regressions, and heat maps. Data Collection/Extraction Methods We defined an NDE as a dispensing event documented by the pharmacy and assumed that each dispensing event represented one naloxone kit (i.e., two doses). We extracted NDEs from local datasets and the Symphony claims dataset. The unit of analysis was the ZIP Code annual quarter. Principal Findings NDEs captured by Symphony exceeded those in local datasets for each time period and location, except in RI following legislation requiring NDEs to be reported to the PDMP. In regression analysis, absolute differences in NDEs between datasets increased substantially over time, except in RI before the PDMP. Heat maps of NDEs by ZIP code quarter showed important variations reflecting where pharmacies may not be reporting NDEs to Symphony or local datasets.
Conclusions
Policymakers must be able to monitor the quantity and location of NDEs in order to combat the opioid crisis. In regions where NDEs are not required to be reported to PDMPs, proprietary pharmaceutical claims datasets may be useful alternatives, with a need for local expertise to assess dataset‐specific variability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center/Boston University School of Medicine, Boston, Massachusetts, USA.
- Boston University School of Public Health, Boston, Massachusetts, USA.
- The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.
- Department of Population Health Sciences, Weill Cornell Medical College, New York City, New York, USA.
- Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
ORCID-Profile: Avik Chatterjee, Jake R Morgan, Brandon D L Marshall, Sean M Murphy
Förderung
- NIDA NIH HHS
- NIGMS NIH HHS
- ACL HHS
- NCIPC CDC HHS
- National Institute on Drug Abuse
- National Center for Injury Prevention and Control
Zitieren
APA
Chatterjee, A., Yan, S., Lambert, A., Morgan, J. R., Green, T. C., Jeng, P. J., Jalali, A., Xuan, Z., Krieger, M., Marshall, B. D. L., Walley, A. Y., & Murphy, S. M. (2023). Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019. Health Services Research. https://doi.org/10.1111/1475-6773.14200
Vancouver
Chatterjee A, Yan S, Lambert A, Morgan JR, Green TC, Jeng PJ, et al. Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019. Health Services Research. 2023. doi:10.1111/1475-6773.14200
BibTeX
@article{Chatterjee2023,
author = {Chatterjee, Avik and Yan, Shapei and Lambert, Audrey and Morgan, Jake R and Green, Traci C and Jeng, Philip J and Jalali, Ali and Xuan, Ziming and Krieger, Maxwell and Marshall, Brandon D L and Walley, Alexander Y and Murphy, Sean M},
title = {Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019},
journal = {Health Services Research},
year = {2023},
doi = {10.1111/1475-6773.14200}
}
EUVIMED